The IGF-1R is frequently overexpressed in human myeloma[13], head and neck cancer[31] and breast cancer[14], suggesting that aberrant IGF-1R expression may contribute to initiation and progression of malignancies. Here, IGF1R is linked to plasma cell myeloma.